Nephrol Dial Transplant (2003) 18: 2122-2127
© 2003 European Renal Association-European Dialysis and Transplant Association
Original Article
Costs of dialysis for elderly people in the UK
1London School of Hygiene and Tropical Medicine and 2Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
Correspondence and offprint requests to: Dr R. P. Grün, Kaiserstrasse 12, D-14109 Berlin, Germany. Email: rp.gruen{at}t-online.de
Background. Growing acceptance rates of elderly patients for dialysis requires a careful planning of renal services expansion. As little is known about the actual resource use in patients 70 years and over, we evaluated the entire range of costs related to treatment, hospitalization, medication and other health and social service use, and assessed the impact of socio-demographic and clinical factors on costs.
Methods. Service use and costs were assessed in a 12-month prospective cohort study of 171 dialysis patients, 70 years of age and over, from four hospital-based renal units in London, UK.
Results. Total costs ranged between £14 940 and £58 250 per annum. The average annual cost was £22 740 [95% confidence interval (CI), £21 47024 020]. The majority of costs were allocated to dialysis treatment and transport (70%), hospitalizations (12%) and medication (12%). Other health and social services accounted for only 6% of total costs. Dialysis and hospitalization costs were £68.4 per day on average. Univariate subgroup analyses showed no significant difference between patients on peritoneal dialysis (£64.5) and haemodialysis (£71.5, P = 0.13). Age 80 years and over and presence of peripheral vascular disease (PVD) were associated with higher daily costs of £73.3 compared with £63.2 in the 7074 age group (P = 0.033) and £76.9 vs £63.8 in patients without PVD (P = 0.022), respectively. Proximity to death was associated with a nearly £40 increase in daily costs (£96.8 vs £59.7; P < 0.001). Multiple linear regression analyses confirmed these findings and showed that age 80 years and over and presence of peripheral and cerebrovascular disease were significant predictors of costs. There was a large but marginally significant difference in costs in patients with cancer. We found no evidence that diabetes was associated with higher dialysis and hospitalization costs.
Conclusions. The costs of providing dialysis for patients 70 years and over are largely shaped by the treatment costs rather than by use of community health and social services. Though age above 80 and co-morbidity are associated with increased resource use, average treatment costs are not higher than estimates for dialysis patients in general. This suggests that there is no case for providing treatment to younger patients and denying it to elderly patients on grounds of cost.
Keywords: economic costs; elderly patients; haemodialysis; health and social service use; peritoneal dialysis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Castrale, D. Evans, C. Verger, E. Fabre, D. Aguilera, J.-P. Ryckelynck, and T. Lobbedez Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF) Nephrol. Dial. Transplant., August 7, 2009; (2009) gfp375v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abdel-Kader, L. Myaskovsky, I. Karpov, J. Shah, R. Hess, M. A. Dew, and M. Unruh Individual Quality of Life in Chronic Kidney Disease: Influence of Age and Dialysis Modality Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 711 - 718. [Abstract] [Full Text] [PDF] |
||||

